Please use this identifier to cite or link to this item: http://sgc.anlis.gov.ar/handle/123456789/1490
Title: Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library
Authors: Tekiel, Valeria 
Alba-Soto, Catalina D 
González Cappa, Stella M 
Postan, Miriam 
Sanchez, Daniel O. 
Issue Date: 25-Feb-2009
Journal: Vaccine 
Abstract: 
The protozoan Trypanosoma cruzi is the etiological agent of Chagas' disease, a major chronic infection in Latin America. Currently, there are neither effective drugs nor vaccines for the treatment or prevention of the disease. Several T. cruzi surface antigens are being tested as vaccines but none of them proved to be completely protective, probably because they represent only a limited repertoire of all the possible T. cruzi target molecules. Taking into account that the trypomastigote stage of the parasite must express genes that allow the parasite to disseminate into the tissues and invade cells, we reasoned that genes preferentially expressed in trypomastigotes represent potential targets for immunization. Here we screened an epimastigote-subtracted trypomastigote cDNA expression library by genetic immunization, in order to find new vaccine candidates for Chagas' disease. After two rounds of immunization and challenge with trypomastigotes, this approach led to the identification of a pool of 28 gene fragments that improved in vivo protection. Sequence analysis of these putative candidates revealed that 19 out of 28 (67.85%) of the genes were hypothetical proteins or unannotated T. cruzi open reading frames, which certainly would not have been identified by other methods of vaccine discovery.
URI: http://sgc.anlis.gob.ar/handle/123456789/1490
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.12.056
Appears in Collections:Publicaciones INP

Show full item record

Page view(s)

6
checked on Jul 4, 2020

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.